Related Experiment Video
Updated: Jul 27, 2026

Protocols for Vaginal Inoculation and Sample Collection in the Experimental Mouse Model of Candida vaginitis
Published on: December 8, 2011
Terconazole for the treatment of vulvovaginal candidiasis
J L Thomason1, S M Gelbart, A V Kellett
1Department of Obstetrics and Gynecology, University of Wisconsin Medical School, Milwaukee 53201-0342.
Abstract:
A double-blind, randomized trial was conducted to evaluate the efficacy and safety of terconazole for vulvovaginal candidiasis. Treatment consisted of daily intravaginal application of one of the following regimens: 80-mg terconazole suppositories for 3 days, miconazole nitrate suppositories for 7 days or placebo suppositories for 7 days. The terconazole and miconazole nitrate groups had significantly higher therapeutic cure rates than did the placebo group. Evaluation of vaginal secretions with microscopic examination showed no evidence of leukocyte proliferation. Proline aminopeptidase activity, present in patients who have bacterial vaginosis, could not be detected in the vaginal secretions from patients with yeast vulvovaginitis.
More Related Videos
Related Concept Videos
Urinary Tract Infection IV: Nursing Management
Cryptococcal Meningitis
Candidiasis
Trichomoniasis
Antifungal Agents
Antiprotozoal Agents

